Search Results

Clinical Significance of Stent Fractures

Endovascular Today interviews Gary M. Ansel, MD

By Gary M. Ansel, MD

Ensuring Satisfaction and Quality Vascular Care as Hospitals Consolidate

Several years ago, Gary M. Ansel, MD, moved from a high-volume private practice into hospital employment, and more recently, when his hospital system began to expand, he took on the role of overseeing the entire system's vascular division. In this interview, Dr. Ansel describes physician compensation models, job satisfaction, and efforts toward establishing high-quality care, regardless of which door a patient passes through.

Superficial Femoral Artery: The Forces Driving Care

By Gary M. Ansel, MD, FACC, and Koen Deloose, MD

Peripheral Vascular Care: A Clinical and Administrative Perspective

Michael R. Jaff, DO, answers questions posed by Gary M. Ansel, MD, FACC, and Koen Deloose, MD, on the challenges of his new role as hospital president and how new regulatory and reimbursement models might affect vascular care delivery.

With Michael R. Jaff, DO; Gary M. Ansel, MD, FACC; and Koen Deloose, MD

One Question… How Will You Apply Drug-eluting Stents in Your SFA Practice?

Featuring Gary M. Ansel, MD; Bruce H. Gray, DO, MSVM, FSCAI; John H. Rundback, MD; and Evan Lipsitz, MD

Mechanical Devices and Acute Limb Ischemia

This increasingly common disorder responds well to alternative treatment approaches.

By Gary M. Ansel, MD; Charles F. Botti, Jr, MD; and Mitchell J. Silver, DO

Primary Stenting of the Iliac Artery

Recent developments in technology have made primary stenting an attractive option.

By Gary M. Ansel, MD

AAA Endografting in the Cath Lab

The requirements for this procedure remain the same wherever it is performed.

By Gary M. Ansel, MD

The VIBRANT Trial

Comparing bare-nitinol stents to stent grafts in long superficial femoral artery lesions in this unique trial.

By Gary M. Ansel, MD, FACC; Patrick J. Geraghty, MD, FACS; Mark Mewissen, MD; and Michael R. Jaff, DO

Relative No-Stent Zones in the Femoropopliteal Arteries

Technological considerations for the infrainguinal arterial bed from one cardiology-based team.

By Gary M. Ansel, MD, FACC; Charles F. Botti Jr, MD, FACC; and Mitchell J. Silver, DO, FACC

A 2007 Update on Treating Nitinol Stent Restenosis

Using Viabahn covered stents to treat restenosis in the superficial femoral artery.

By Gary M. Ansel, MD, FACC; Charles F. Botti, Jr, MD; Melinda Taylor, RN; and Mitchell J. Silver, DO

Ask the Experts: How Do You Define ‘High Risk for Restenosis'?

With Gary M. Ansel, MD; Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM; Marianne Brodmann, MD; Koen Deloose, MD; Andrew Holden, MBChB, FRANZCR, EBIR; John H. Rundback, MD; and Peter A. Schneider, MD

Tailor-Made CLI Sheaths, Catheters, and Wires

The right equipment can make all the difference in successful procedural outcomes.

By Gary M. Ansel, MD

Creative Access Techniques for CTOs

New technology and unconventional approaches help to maximize success in difficult cases.

By Charles F. Botti, Jr, MD, and Gary M. Ansel, MD

Are Stent Fractures Significant?

Before condemning–or even categorizing–the technology as a whole, we need to pinpoint the true factors that impact outcome.

By Gary M. Ansel, MD